GrowBLOX Files Third Patent for Its Proprietary Growing Chambers

GrowBLOX Sciences (OTCMKTS:GBLX) announced that it was filed its third strategic patent for its proprietary automated growth chambers for growing and curing medical botanicals.
As quoted in the press release:

Previously filed patents had focused on the method and apparatus that comprises the original GrowBLOX chambers.
The new patent covers the TissueBLOX(TM), VegBLOX(TM), GrowBLOX(TM), and CureBLOX(TM), which form a comprehensive growth system characterized by real-time monitoring, managing and controlling the operation of the integrated system based upon real-time sensed parameters.
According to the new patent application, the GrowBLOX(TM) Technology Suite is “an integrated plant cultivation system for optimizing, promoting and enhancing the rapid growth of a least one plant during one or more stages of its development cycle.”

Craig Ellins, CEO of GrowBLOX, commented:

With the filing of this latest application, we enable the world to see not only what our technology can do for the development of pharmaceutical grade medical cannabis, but also what we can do to standardize many plant-based therapeutic agents. Today, many such therapeutic agents can be produced in quantity only by inferior techniques such as recombinant expression systems in yeast or bacteria. We believe that soon our technology will help to remedy that problem by standardizing clinical therapies formed from complex plant-based mixtures.

Click here to read the full GrowBLOX Sciences (OTCMKTS:GBLX) press release.